Millennium Management Reduces KALA BIO Stake as of Dec 31, 2023

TL;DR

**Millennium Management cut its KALA BIO stake, watch for potential stock impact.**

AI Summary

Millennium Management LLC, through its affiliates Integrated Core Strategies (US) LLC and Millennium Group Management LLC, has updated its ownership stake in KALA BIO, Inc. (formerly Kala Pharmaceuticals, Inc.) as of December 31, 2023. This amendment (SC 13G/A) indicates that their collective beneficial ownership of KALA BIO's common stock has decreased, as they are no longer reporting a significant stake that would require a new filing. This matters to investors because it signals that a major institutional investor has reduced its position, which could be interpreted as a loss of confidence or a reallocation of capital, potentially influencing other investors' decisions regarding KALA BIO stock.

Why It Matters

A significant institutional investor reducing its stake can signal a shift in sentiment or strategy, potentially impacting KALA BIO's stock price and investor confidence.

Risk Assessment

Risk Level: medium — The reduction in a major institutional holding could indicate a negative outlook or a strategic shift by the investor, potentially leading to downward pressure on the stock.

Analyst Insight

A smart investor would monitor KALA BIO's stock performance closely for any significant price movements and research the reasons behind Millennium Management's reduced stake, considering if it signals fundamental issues or merely portfolio rebalancing.

Key Numbers

• 483119202 — CUSIP Number (identifies KALA BIO, Inc.'s common stock)
• 0001479419 — Central Index Key (CIK) (identifies KALA BIO, Inc. in SEC filings)
• 0001319244 — Central Index Key (CIK) (identifies Integrated Core Strategies (US) LLC in SEC filings)

Key Players & Entities

• KALA BIO, Inc. (company) — the subject company of the filing, formerly Kala Pharmaceuticals, Inc.
• Integrated Core Strategies (US) LLC (company) — a reporting person and affiliate of Millennium Management LLC
• Millennium Management LLC (company) — a group member and parent entity of the reporting persons
• Israel A. Englander (person) — a group member associated with Millennium Management LLC
• December 31, 2023 (date) — the date of the event requiring the filing of this statement

Forward-Looking Statements

• KALA BIO's stock price may experience short-term volatility due to the perceived loss of institutional confidence. (KALA BIO, Inc.) — medium confidence, target: Q1 2024
• Other institutional investors might re-evaluate their positions in KALA BIO following Millennium Management's reduction. (Institutional Investors) — medium confidence, target: Q2 2024

FAQ

Key Financial Figures

• $0.001 — me of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securiti

Filing Documents

• KALA_SC13GA1.htm (SC 13G/A) — 92KB
• 0001319244-24-000016.txt ( ) — 94KB

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); CUSIP No. 483119202 SCHEDULE 13G Page 7 of 11 (g) o A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: See response to Item 9 on each cover page. (b) Percent of Class: See response to Item 11 on each cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote See response to Item 5 on each cover page. CUSIP No. 483119202 SCHEDULE 13G Page 8 of 11 (ii) Shared power to vote or to direct the vote See response to Item 6 on each cover page. (iii) Sole power to dispose or to direct the disposition of See response to Item 7 on each cover page. (iv) Shared power to dispose or to direct the disposition of See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ .

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group See Exhibit I.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 483119202 SCHEDULE 13G Page 9 of 11 Exhibits: Exhibit I: Joint Filing Agreement, dated as of January 26, 2024, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. CUSIP No. 483119202 SCHEDULE 13G Page 10 of 11 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: January 26, 2024 INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM GROUP MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel /s/ Israel A. Englander Israel A. Englander CUSIP No. 483119202 SCHEDULE 13G Page 11 of 11 EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of KALA BIO, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amende

View Full Filing

View this SC 13G/A filing on SEC EDGAR